Skip Navigation


Human Molecular Genetics Advance Access originally published online on March 31, 2008
Human Molecular Genetics 2008 17(13):2039-2046; doi:10.1093/hmg/ddn101
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
17/13/2039    most recent
ddn101v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Klos, K.
Right arrow Articles by Hixson, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klos, K.
Right arrow Articles by Hixson, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

APOE/C1/C4/C2 hepatic control region polymorphism influences plasma apoE and LDL cholesterol levels

Kathy Klos1,*, Lawrence Shimmin1, Christie Ballantyne2, Eric Boerwinkle1, Andrew Clark3, Josef Coresh4, Craig Hanis1, Kiang Liu5, Scott Sayre1 and James Hixson1

1 Human Genetic Center, University of Texas Health Science Center at Houston, Houston, TX, USA 2 Center for Cardiovascular Disease Prevention, Baylor College of Medicine and the Methodist DeBakey Heart Center, Houston, TX, USA 3 Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY, USA 4 Welch Center for Prevention, Epidemiology and Clinical Research, The Johns Hopkins Medical Institutions, Baltimore, MD, USA 5 Department of Preventive Medicine, Northwestern University, Chicago, IL, USA

* To whom correspondence should be addressed at: University of Texas Health Science Center at Houston School of Public Health Human Genetics Center, PO Box 20186, Houston, TX 77225, USA. Tel: +1 7135009914; Fax: +1 7135000900; Email: kathy.klos{at}uth.tmc.edu

Received October 23, 2007; Accepted March 26, 2008

We characterized 102 kb of chromosome 19 containing the apolipoprotein (APO) E/C1/C4/C2 cluster and two flanking genes for common DNA variants associated with plasma low-density lipoprotein cholesterol (LDL-C) level. DNA variants were identified by comparing sequences of 48 haploid hybrid cell lines. We genotyped participants (1943 Whites and 2046 African-Americans) of the Coronary Artery Risk Development in Young Adults study for 115 variants. After controlling for the effects of the APOE {varepsilon}2/3/4 polymorphism, a single nucleotide polymorphism, rs35136575, in the downstream hepatic control region 2 (HCR-2) was associated with LDL-C in Caucasians (P = 0.0004), accounting for 1% of variation. We genotyped rs35136575 in the Atherosclerosis Risk in Communities (ARIC) cohort (3679 African-Americans and 10 427 Whites) and in the Genetic Epidemiology Network of Arteriopathy (GENOA) sibships (1381 African-Americans in 592 sibships, 1116 Caucasians in 503 sibships and 1378 Mexican-Americans in 416 sibships), finding association with LDL-C level in ARIC Caucasians (P = 0.0064). Lower plasma LDL-C was observed with the rare allele. Plasma apoE level was strongly associated with HCR-2 variant genotype in all three GENOA samples (P ≤ 0.002), indicating an effect on apoE concentration. Patterns of association for plasma apo A-I, apoB, LDL-C, high-density lipoprotein cholesterol, total cholesterol and triglyceride levels with rs35136575 in the population-based samples evaluated in this study suggest a pleiotropic effect that may be context-dependent.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 NeurologyHome page
P. van Vliet, R.G.J. Westendorp, P. Eikelenboom, H. C. Comijs, M. Frolich, E. Bakker, W. van der Flier, and E. van Exel
Parental history of Alzheimer disease associated with lower plasma apolipoprotein E levels
Neurology, September 1, 2009; 73(9): 681 - 687.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.